Get ready for "the next step" Dr. Dalton The next

New Post Public Reply Private Reply Replies (0) Message Board
Wharfrat
387
Get ready for "the next step" Dr. Dalton

The next step

Dr. Dalton’s next steps are to provide:

Provide telehealth and Mental Health and Substance Abuse services;

Continue to help break down barriers and support economic pathways by providing knowledge about entrepreneurial success and creating wealth.

Secrets to success

“If you’re following your passion, building on what you know and use technology to enhance your position in business then you will be a disruptor to the usual and customary. Things constantly change” he said. “That’s worked for me.”
“You have to learn how to balance your businesses, career and family,” he observed. “The key to a lot of things in business is based on new technology. Stay ahead of it.

“Pharmacists will depend on technology more to be able do telehealth, and the medical environment will be dependent on technology for electronic medical records and services.

“I’m excited about the new technology coming along, which will make the healthcare system more cost effective,” he said.

Acquisitions and Mergers
In 1989, he left Rite Aid to acquire Peoples Drug Stores with an investment group including Robert Bass of Texas.


Dr. Dalton served briefly as a senior vice president at Peoples Drug Stores, before acquiring the Sherman Management Group, one of the first worker compensation pharmacy benefit management companies in the United States, and the Medical Service Agency, where he served as chairman, president, and CEO.

In November 1994, he merged Sherman Management and Medical Services into MEDNET, a public company listed on NASDAQ. Dr. Dalton served as executive vice president of MEDNET and president of Medi-Claim, a wholly owned subsidiary of MEDNET.

His next venture, Managed Care Rx, a specialty pharmaceutical provider for assisted living facilities, nursing homes, and prisons, was merged with a subsidiary of Bergen Brunswick, a drug wholesale company with sales in excess of $14 Billion.
_____________________________________________________________
Technology and Medical care

Later, Dr. Dalton launched Health Resources, Inc. as founding president and CEO.

Health Resources the first African American pharmaceutical company in the United States and it is also a national discount pharmacy benefit management company that has contracted with more than 50,000 retail pharmacies for the fulfillment of prescription orders. Black Enterprise magazine has recognized Health Resources in top 100 lists for over 25 years.

Dr. Dalton is also president and CEO of Univec Inc., which manufactures and distributes specialty pharmaceuticals to hospitals, physicians, pharmacies, and clinics. Physician and Pharmaceutical Services Inc. is the pharmacy sample services division of Univec that provides prescription “starter-script” samples programs for physicians to give to their patients. Among his many responsibilities, Dr. Dalton serves as the chairman of Wellness Healthcare Inc., a telehealth, and wellness company.

________________________________________________________________
http://www.blackengineer.com/article/where-th...ceuticals/

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 201

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 148

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 215

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Travel: The Rise of Recreational Vehicles

Updated Category News Views 118

Understanding the Recreational Vehicle Market The recreational vehicle (RV) market has become a beacon for travel enthusiasts, illustrating a profound shift toward enhancing the travel experience. These vehicles offer not just transportation, but a home on wheels, combining adventure with convenience. As of now, the global RV market size is valued significantly, with...

Continue Reading
Explore Data Quality Trends at FWRD 2025 Virtual Event

Updated Category News Views 245

Ataccama Opens Registration for FWRD 2025 BOSTON — Ataccama, the data trust company, is excited to announce that registration is now open for FWRD 2025, its major virtual event designed for Chief Data Officers (CDOs) and data leaders navigating the complexities of artificial intelligence and data management. This groundbreaking event will take place on November 6 and...

Continue Reading
Enhancements in Event Ticketing with Apple Wallet and Ticketmaster

Updated Category News Views 125

Exciting Changes in Ticketing with Apple Wallet Live Nation Entertainment’s Ticketmaster has announced a significant enhancement for event ticketing by integrating support for richer tickets within Apple Inc.’s Wallet. This upgrade, stemming from the new features introduced with iOS 18, is set to revolutionize how concert and event goers manage their tickets. What...

Continue Reading
Zealand Pharma To Host Conference Call for Q2 2025 Results

Updated Category News Views 183

Zealand Pharma's Upcoming Conference Call Zealand Pharma A/S, a prominent biotechnology firm known for its innovative peptide-based medicines, has announced an important event on August 14, 2025. The company will hold a conference call at 2:00 PM CET, equivalent to 8:00 AM ET, to discuss its financial results for the second quarter of 2025. Key Participants in the Call...

Continue Reading
Juniper Biosciences Secures $40 Million for Future Projects

Updated Category News Views 249

Juniper Biosciences Secures Significant Funding In a remarkable move to propel its innovative projects forward, Juniper Biosciences LLC has successfully closed an oversubscribed and upsized $40 million seed financing round. This effort was spearheaded through its parent company, Juniper Radiopharma LLC, and co-led by NovaCapital alongside several high-net-worth investors...

Continue Reading